HealthcareServices

Urticaria Market Report 2026: Strategic Insights and Revenue Outlook

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the urticaria market from 2026–2035 with trusted insights from The Business Research Company

How is the Urticaria Market size predicted to change over the forecast window of 2026–2035?

The urticaria market has experienced rapid expansion in recent years. It is projected to grow from $4.76 billion in 2025 to $5.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.9%. The increase observed in the historic period is attributable to the increasing prevalence of allergic skin conditions, broader use of antihistamines, the expansion of dermatology treatment services, rising awareness of chronic urticaria, and the availability of prescription therapies.

The urticaria market is anticipated to experience substantial growth in the upcoming years. By 2030, it is projected to expand to $10.71 billion, achieving this at a compound annual growth rate (CAGR) of 17.5%. This anticipated growth during the forecast period is largely driven by factors such as the increasing acceptance of biologic treatments, a rising need for long-acting therapies, an intensified focus on immune-modulating drugs, the proliferation of specialty dermatology clinics, and growing investment in allergy and immunology research. Furthermore, significant trends for this period include the accelerated development of biologic and monoclonal antibody therapies, an expanding application of personalized treatment methods, a growing emphasis on chronic urticaria management, the wider availability of advanced antihistamine formulations, and an increased priority placed on long-term disease control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23554&type=smp

Which Drivers Are Contributing To The Expansion Of The Urticaria Market?

Enhanced understanding and management of skin conditions are projected to propel the expansion of the urticaria market in the future. Growing environmental pollution contributes to a rise in skin allergies and various dermatological issues, thereby fueling the need for greater awareness and sophisticated treatment options. Urticaria plays a role in fostering skin disease awareness and improving treatment methodologies through its demonstration of immune system reactions, stimulating further research, refining diagnostic processes, and progressing specific therapeutic interventions. As an illustration, in February 2024, The Skin Cancer Foundation, a US-based nonprofit, disclosed that approximately 1 in 5 Americans will experience skin cancer by the age of 70, with more than 2 deaths happening hourly across the U.S. This information underscores the critical necessity of preventative actions, considering that experiencing five or more sunburns doubles an individual’s risk of developing melanoma. Consequently, the heightened awareness and improved treatment of skin diseases are serving as a significant impetus for the growth of the urticaria market.

What Segment Classifications Make Up The Urticaria Market?

The urticaria market covered in this report is segmented –

1) By Type: Acute Urticaria, Chronic Urticaria

2) By Drug Class: Antihistamines, Anti-inflammation Medications, Antidepressants, Monoclonal Antibodies, Other Drug Classes

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Urticaria: Allergic Urticaria, Infectious Urticaria, Drug-Induced Urticaria, Contact Urticaria

2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU)

Which Market Trends Are Opening Growth Opportunities In The Urticaria Market?

Leading companies within the urticaria market are prioritizing the development of advanced therapeutic solutions for chronic spontaneous urticaria (CSU) by targeting mast cell activation, specifically through innovative mast cell inhibitor antibodies. These antibodies are targeted monoclonal antibodies engineered to block the activation or degranulation of mast cells by inhibiting specific receptors or signaling pathways, which in turn reduces allergic reactions, inflammation, and other related disorders. An illustration of this focus is seen in May 2024, when Allakos Inc., a US-based biotechnology company, announced the commencement of a Phase 1 clinical trial for AK006. This treatment is specifically designed for chronic spontaneous urticaria (CSU). AK006 uniquely targets both IgE-dependent and IgE-independent mast cell activation pathways, which could lead to wider effectiveness for patients resistant to antihistamines or previous biologic treatments. By specifically inhibiting mast cell activity through the Siglec-6 receptor, AK006 aims to offer a more complete and enduring approach to CSU management, representing a substantial stride in both urticaria treatment and immunotherapy research.

Which Key Players Are Driving Competition In The Urticaria Market?

Major companies operating in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd, Argenx SE, Allakos Inc, AstraZeneca plc, Kiniksa Pharmaceuticals Ltd, United BioPharma Inc, Celldex Therapeutics Inc, Yuhan Corporation, Hangzhou Highlightll Pharmaceutical Co Ltd, Evommune Inc, Rapt Therapeutics Inc, Enanta Pharmaceuticals Inc, UCB Pharma

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/urticaria-global-market-report

How Does The Urticaria Market Perform Across Major Global Regions?

North America was the largest region in the urticaria market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urticaria market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Urticaria Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23554&type=smp

Browse Through More Reports Similar to the Global Urticaria Market 2026, By The Business Research Company

Allergic Rhinitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Dermatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Ursolic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/ursolic-acid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795